Categorization and Reimbursement regulation

the Constitutional Court, in its ruling of 30 May 2017, annulled the key provisions of Act No. 48/1997 Coll., on Public Health Insurance regulating the mechanism of determining the amount of reimbursement of medical devices from public health insurance when providing outpatient health services. The Constitutional Court annulled the reimbursement regulation of so-called voucher medical devices (e.g. incontinence pads, prostheses, wheelchairs, hearing aids or glucometers and other aids for diabetics). Specifically, those provisions that determined that the insured person’s entitlement to reimbursement for medical devices is implemented in the least economically demanding option, which health insurens companies determine through market research.

On 1 January 2019, the amendment to the Health Insurance Act came into force, bringing new rules for the reimbursement regulation of medical devices prescribed on a voucher and reimbursed from public health insurance.

If you have a question that you haven’t found or if the answer is not clear, please email uhrzp@sukl.gov.cz.

Reference to the supplementary methodology of the General Health Insurance Company of the Czech Republic (VZP), which regulates the procedure for accounting for reimbursement of provided individually manufactured medical devices based on a voucher submitted by the insured.

VZP – Doplňující metodika schvalování, výdeje a úhrady individuálně zhotovovaných ZP a jejich oprav a úprav (Czech only)